A baby formula plant in Sturgis, Mich., which resumed production less than two weeks ago after a monthslong closure that exacerbated a nationwide shortage, has again shut down after parts of the facility were flooded during a severe storm.
The company that operates the plant, Abbott Nutrition, said on Wednesday that it was forced to stop production of its EleCare specialty formula in Sturgis, one of its five manufacturing sites, after severe weather moved through southwestern Michigan on Monday.
In February, Abbott closed the plant and recalled batches of its Similac, Alimentum and EleCare formulas after the Food and Drug Administration received four consumer complaints of bacterial infections related to the formulas.
On Wednesday, the company said that it was assessing damage from the storm and cleaning the plant, which would delay production and distribution for a few weeks, but that it had sufficient supplies of EleCare and most of its specialty and metabolic formulas to meet demand until new formula is available.
Read More on the Baby Formula Shortage
- Understand the Shortage: With just a handful of companies making infant formula for the U.S. market, the shutdown of an Abbott Laboratories plant had an outsize effect.
- Premature Babies: Many newborns who spend time in the NICU rely on specialized formula to thrive once they come home. As the shortage continues, their parents can’t find it anywhere.
- Pumping for the Cause: In New York City, the shortage has prompted a huge volunteer effort, with some mothers donating their excess supply of breast milk to help other parents.
- An Emotional Toll: The shortage is forcing many new mothers to push themselves harder to breastfeed, with some even looking for ways to start again after having stopped.
“These products are being released to consumers in need in coordination with health care professionals,” it said.
Robert M. Califf, the F.D.A. commissioner, said that the agency had been informed about the stoppage but that it was not expected to have much impact, given increased imports of formula as well as production by Abbott and other manufacturers.
“While this is an unfortunate setback and a reminder that natural weather events can also cause unforeseen supply chain disruptions, I want to reassure consumers the all-of-government work to increase supply means we’ll have more than enough product to meet current demand,” he said in a statement on Twitter.
He made similar remarks in a Senate committee hearing on Thursday, saying that the F.D.A. was working closely with Abbott to get the plant up and running again “as quickly as we possibly can.”
The storm disrupted power and caused wind damage, and the city’s municipal airport recorded 1.5 inches of rain, the Sturgis Journal reported.
The stoppage at the plant was the latest twist in the baby formula shortage in the United States, which started earlier this year, when pandemic-related supply chain issues, including a scarcity of some ingredients, made it difficult for parents to find formula.
After the shutdown in February, Abbott said it increased production at other manufacturing plants in the United States and at one in Ireland.
Abbott and other producers have been ramping up production as the government eases import regulations. “This means that the total amount of formula available, even before the Sturgis plant is back in production, exceeds the demand for formula prior to the recall,” Dr. Califf, the F.D.A. commissioner, said.
Navigating the Baby Formula Shortage in the U.S.
A growing problem. A nationwide shortage of baby formula — triggered in part by supply-chain issues and worsened by a recall by the baby food manufacturer Abbott Nutrition — has left parents confused and concerned. Here are some ways to manage this uncertainty:
On June 4, Abbott said that it had resumed production of EleCare at the Sturgis plant for an expected release to consumers around June 20, and that it was “working hard” to restart production of Similac and other formulas. But that timing appears unclear after the flooding.
“Once the plant is re-sanitized and production resumes, we will again begin EleCare production, followed by specialty and metabolic formulas,” the company said in its statement late on Wednesday. “In parallel, we will work to restart Similac production at the plant as soon as possible.”
The baby formula shortage had threatened to become a political and public health disaster. President Biden invoked the Defense Production Act to increase production and authorized the use of Defense Department planes for “Operation Fly Formula.”
In May, the first in a series of international shipments of infant formula was flown into the United States under the program, to speed up imports and to start getting stock in stores. The seventh shipment takes place on Thursday when Nestlé formula is flown from Switzerland to Louisville, Ky., the White House said.
Read the full article here